Flexible biometrics support for biotech teams, from study design to submission.
Whether you need end-to-end biometrics support or targeted expertise, our teams adapt to your trial needs – providing flexible, high-quality delivery with the priortization and focus you need.
Accelerate Study Success: Automate Workflows, Future-Proof Results, and Streamline Delivery
We manage the full biometrics lifecycle, from study design to final submission, ensuring quality, efficiency, and smooth delivery.
We offer flexible single-service biometrics solutions that seamlessly integrate with your clinical teams and other vendors, ensuring collaboration and clear communication to keep your studies on track.
We deliver seamless integrated analyses and submission-ready outputs, helping you meet global regulatory requirements efficiently and with confidence.
We provide independent, expert DMC services that safeguard patient safety, protect study integrity, and deliver timely, compliant analyses.
We deliver tailored rescue and vendor transition services, performing expert technology assessments to identify risks, ensure system compatibility, and realign programs for study success.
We offer unified portfolio oversight and dedicated support from a consistent team, ensuring seamless project continuity, simplified management, and communication tailored to your needs
We deliver rapid, end‑to‑end biometrics solutions for complex and time‑critical studies, ensuring quality and delivery certainty.
Partnering with Veramed means more than just access to tailored solutions, it’s about gaining a collaborative partner dedicated to your success.
With specialist biometrics CRO expertise, proven support across Phase I-IV trials, and flexible engagement tailored to your needs, we work as an extension of your team to deliver high-quality, regulatory-ready outputs.
Our collaborative, responsive teams are committed to supporting your study goals from start to finish.
Our experienced data managers, statisticians and programmers keep your studies moving, minimizing bottlenecks and avoiding costly delays.
From clinical trial outputs to real-world evidence, our analyses help you demonstrate treatment effectiveness and support market access.
High-quality data management and independent DMC support enable you to make confident, evidence-driven decisions and reduce risk.
If a study is off-track, our rapid-response rescue services minimize disruptions, safeguarding timelines and investment.
Integrated analysis and submission expertise ensure your studies meet global regulatory standards the first time. Delivering high-quality, regulatory-ready outputs is central to our approach, helping reduce risk and support successful submissions.
Project-based biometrics solutions provide flexible, high-quality support for specific clinical trial needs, including data management, statistical analysis, DMC oversight, and regulatory submission preparation. These services are tailored to each study’s scope and timeline.
Veramed offers data management, integrated analysis and submission services, independent Data Monitoring Committee (DMC) support, and full end-to-end biometrics solutions from study design to final submission.
Veramed’s integrated analysis and submission solutions are designed to meet global regulatory standards, ensuring your clinical trial outputs are accurate, compliant, and submission-ready the first time.
Yes, Veramed offers rapid-response rescue solutions to help recover studies that are off-track, minimizing disruptions and safeguarding timelines and investments.
Independent DMC support from Veramed ensures patient safety, protects study integrity, and provides timely, compliant analyses that support confident decision-making throughout your trial.
Veramed’s experienced biometrics teams work collaboratively to minimize bottlenecks, streamline processes, and keep your studies progressing efficiently from start to finish.
Veramed provides high-quality analyses of clinical trial data and real-world evidence to demonstrate treatment effectiveness, support market access, and inform strategic decisions.
